Loading…
Avaria Health & Beauty Corp., a manufacturer of over-the-counter drug products including hand sanitizers and topical products, was cited for significant Current Good Manufacturing Practice (CGMP) violations that resulted in adulterated drugs. The company failed to conduct required identity testing on incoming drug components, specifically failing to adequately test glycerin and other high-risk ingredients for contamination with diethylene glycol (DEG) or ethylene glycol (EG). This violation of 21 CFR 211.84(d)(1) represented a critical gap in component verification procedures that the FDA deemed insufficient to ensure product safety and identity.